SCHEMBL6711491

SCHEMBL6711491

O=C(Nc1ccc(Cl)cc1-c1noc(=O)[nH]1)c1cc2cccc(NC(=O)C3CCC3)c2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.41
PLCG2 P16885 1/20 0.39
GRM5 P41594 1/20 0.37
PLA2G7 Q13093 1/20 0.36
NR2E3 Q9Y5X4 1/20 0.36
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 1/20 0.35
PTK2B Q14289 1/20 0.35
NHERF1 O14745 1/20 0.35
GRM4 Q14833 1/20 0.35
STK33 Q9BYT3 1/20 0.35
GSK3B P49841 1/20 0.35
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
STAT3 P40763 1/20 0.34
STAT1 P42224 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708935 0.98 GRIK1 (0.41) GRIK1PLCG2GRM5PLA2G7NR2E3
SCHEMBL6708773 0.98 GRIK1 (0.41) GRIK1PLCG2GRM5PLA2G7NR2E3
SCHEMBL6707685 0.97 GRIK1 (0.42) GRIK1PLCG2PLA2G7KMT2APTK2B
SCHEMBL6710073 0.91 GRIK1 (0.39) GRIK1PLCG2PLA2G7PTK2BNHERF1
SCHEMBL6707746 0.90 GRIK1 (0.39) GRIK1ALDH1A1POLBNPC1RAB9A
SCHEMBL6707970 0.89 GRIK1 (0.39) GRIK1PLCG2PLA2G7PTK2BNHERF1
SCHEMBL6707967 0.89 GRIK1 (0.39) GRIK1PLCG2PLA2G7PTK2BNHERF1
SCHEMBL6707972 0.89 GRIK1 (0.39) GRIK1PLCG2PLA2G7PTK2BNHERF1
SCHEMBL6709354 0.89 GPR35 (0.40) GRIK1KMT2AALDH1A1POLBNPC1
SCHEMBL6709906 0.88 GSK3B (0.37) PLA2G7ALDH1A1GSK3BTP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885PLCG2 4289/4885GRM5 4139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.